Articles

June 11, 2019 Pride 2019 - Alnylam Celebrates Diversity at Boston Pride Parade This past Saturday, Alnylam joined approximately 750,000 people gathered in Boston for the 2019 Boston Pride Parade to honor the 50th anniversary of the... Read More ›
June 10, 2019 Alnylam Named a Best Workplace in Switzerland & UK Alnylam's offices in Maidenhead, UK and Zug, Switzerland were both recently named to Great Place to Work's Best Workplaces for 2019. Read More ›
April 11, 2019 Letter to the Editor: Federal Research is Important, but Companies Turn it Into Actual Tre ... John Maraganore wrote a Letter to the Editor in The Washington Post about the importance of federal research... Read More ›
March 29, 2019 Team Alnylam Hits the Court to Support Massachusetts Special Olympics Alnylam joined more than a dozen biotech companies in the annual Bioball Basketball Tournament to support the Massachusetts Special Olympics. Read More ›
February 28, 2019 Meet the 2018 Advocacy for Impact Grants Recipients We are very pleased to announce the 2018-19 Advocacy for Impact Grants recipients and share more information about their initiatives. Advocacy for Impact is... Read More ›
February 20, 2019 Alnylam Named a Fast Company World's Most Innovative Company for 2019 Alnylam has been named #3 in Biotech on Fast Company's World's 50 Most Innovative Company for 2019. Read More ›
December 11, 2018 John Maraganore Named to Bloomberg 50 List for 2018 Alnylam CEO John Maraganore has been named to the Bloomberg 50 list for 2018. Read More ›
November 16, 2018 Alnylam Named a Boston Globe Top Place to Work for the 4th Year in a Row Alnylam has been named to the Boston Globe's list of Top Places to Work for 2018 marking our fourth year in a row on the list.  We are ranked #18 out of the... Read More ›
September 10, 2018 A Triumph of Perseverance Over Interference [Nature Biotechnology] The following Editorial appeared in Nature Biotechnology (36,775 2018) on September 6, 2018... "A triumph of perseverance over interference"... Read More ›
August 11, 2018 New Kind of Drug, Silencing Genes, Gets FDA Approval [Wall Street Journal] The following article appeared in The Wall Street Journal on August 10, 2018... "New Kind of Drug, Silencing Genes, Gets FDA Approval"... Read More ›
Subscribe to Articles